<DOC>
	<DOC>NCT02330705</DOC>
	<brief_summary>Evaluation of the effect of altering the timing of human chorionic gonadotropin (HCG) administration on the clinical pregnancy rate in intrauterine insemination (IUI) cycles.</brief_summary>
	<brief_title>Timing of HCG Administration in IUI Cycles</brief_title>
	<detailed_description>Women will be randomly divided into 3 groups; the first group will undergo IUI at the time HCG administration, the second group will undergo IUI 12 hours after HCG administration and the third group will undergo IUI 34-36 hours after HCG administration.</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<criteria>Mild male factor infertility or unexplained infertility. Advanced male factor infertility. Polycystic ovary syndrome (PCOS) as defined by the Rotterdam criteria. Endometriosis. Tubal disease. Uterine abnormalities or myoma. Previous uterine surgery. Metabolic or hormonal abnormalities.</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Intrauterine insemination</keyword>
	<keyword>IUI</keyword>
	<keyword>HCG</keyword>
</DOC>